Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract.

ABSTRACT:

Objective

To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor.

Design, setting, and participants

The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry included 1134 UTUC patients with or without concurrent bladder tumor treated between 2014 and 2019.

Results

In 218 (19.2%) cases, concurrent bladder tumor was present, while in 916 (80.8%) patients, no bladder cancer was found. In the multivariable Cox regression analysis, concomitant bladder tumor (hazard ratio (HR) 1.562, 95% confidence interval (CI) 0.954-2.560, p = 0.076) indicated a trend associated with recurrence-free survival for UTUC. Further data dissection confirmed that concomitant bladder tumor is

SUBMITTER: Liu K 

PROVIDER: S-EPMC9776685 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature